medigraphic.com
ISSN 2594-1526 (Digital)
ISSN 0028-3746 (Impreso)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2017, Número 1

<< Anterior

Neumol Cir Torax 2017; 76 (1)


El síndrome de apnea obstructiva del sueño como factor de riesgo para enfermedades cardiovasculares y su asociación con hipertensión pulmonar

Morales-Blanhir JE, Valencia-Flores M, Lozano-Cruz OA

Idioma: Español
Referencias bibliográficas: 78
Paginas: 51-60
Archivo PDF: 448.07 Kb.


RESUMEN

Existe evidencia sólida de que el síndrome de apnea obstructiva del sueño (SAOS) es un factor de riesgo cardiovascular. Los eventos de obstrucción de la vía aérea durante el sueño predisponen a alteraciones como hipertensión arterial sistémica, cardiopatía isquémica y enfermedad vascular cerebral, representando éstas un impacto negativo en la salud pública de nuestro medio. El SAOS se asocia, además, con disfunción endotelial, arritmias, insuficiencia cardíaca e hipertensión pulmonar (HP). Estas asociaciones han generado el desarrollo constante de evidencia que permite comprender el impacto independiente de este síndrome. En esta revisión de la literatura publicada en MEDLINE que es la base de datos más importante de la National Library of Medicine, tiene como objetivo mostrar al SAOS como un factor de riesgo cardiovascular, con especial atención a su asociación con el desarrollo de HP por ser un factor predisponente de disfunción ventricular.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163(1):19-25.

  2. Somers VK, White DP, Amin R, et al.; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118(10):1080-1111. doi: 10.1161/CIRCULATIONAHA.107.189375.

  3. Floras JS. Sleep apnea and cardiovascular risk. J Cardiol 2014;63(1):3-8. doi: 10.1016/j.jjcc.2013.08.009.

  4. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378-1384.

  5. Li M, Hou WS, Zhang XW, Tang ZY. Obstructive sleep apnea and risk of stroke: a meta-analysis of prospective studies. Int J Cardiol 2014;172(2):466-469. doi: 10.1016/j.ijcard.2013.12.230.

  6. Hohl M, Linz B, Böhm M, Linz D. Obstructive sleep apnea and atrial arrhythmogenesis. Curr Cardiol Rev 2014;10(4):362-368.

  7. Kasai T. Sleep apnea and heart failure. J Cardiol 2012;60(2):78-85. doi: 10.1016/j.jjcc.2012.05.013.

  8. Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis 2009;51(5):363-370. doi: 10.1016/j.pcad.2008.06.001.

  9. Loke YK, Brown JW, Kwok CS, Niruban A, Myint PK. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2012;5(5):720-728.

  10. Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens 2015;29(12):705-712. doi: 10.1038/jhh.2015.15

  11. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003;41(9):1429-1437.

  12. Korcarz CE, Peppard PE, Young TB, et al. Effects of obstructive sleep apnea and obesity on cardiac remodeling: The Wisconsin Sleep Cohort Study. Sleep 2016;39(6):1187-1195. doi: 10.5665/sleep.5828.

  13. Dong JY, Zhang YH, Qin LQ. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis 2013;229(2):489-495. doi: 10.1016/j.atherosclerosis.2013.04.026.

  14. Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou JB. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68(6):566-572.

  15. Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities. Chest 2015;147(1):266-274. doi: 10.1378/chest.14-0500.

  16. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien Il: American Academy of Sleep Medicine; 2014.

  17. Young T. Rationale, design and findings from the Wisconsin Sleep Cohort Study: Toward understanding the total societal burden of sleep disordered breathing. Sleep Med Clin 2009;4(1):37-46.

  18. Hansel B, Cohen-Aubart F, Dourmap C, Giral P, Bruckert E, Girerd X. [Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension]. Arch Mal Coeur Vaiss 2007;100(8):637-641.

  19. Drager LF, Genta PR, Pedrosa RP, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010;105(8):1135-1139. doi: 10.1016/j.amjcard.2009.12.017.

  20. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001;19(12):2271-2277.

  21. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004;110(4):364-367.

  22. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010;5(8):e12065. doi: 10.1371/journal.pone.0012065.

  23. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5(2):136-143. doi: 10.1513/pats.200709-155MG.

  24. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 2008;5(2):185-192. doi: 10.1513/pats.200708-137MG.

  25. Bouscoulet LT, Vázquez-García JC, Muino A, et al.; PLATINO Group. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med 2008;4(6):579-585.

  26. Valencia-Flores M, Orea A, Castano VA, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000;8(3):262-269.

  27. Bloch KE, Latshang TD, Ulrich S. Patients with obstructive sleep apnea at altitude. High Alt Med Biol 2015;16(2):110-116. doi: 10.1089/ham.2015.0016.

  28. Valencia-Flores M, Mokhlesi B, Santiago-Ayala V, et al. Intermittent hypoxemia and sleep fragmentation: associations with daytime alertness in obese sleep apnea patients living at moderate altitude. Sleep Med 2016;20:103-109. doi: 10.1016/j.sleep.2016.01.002

  29. Bazurto Zapata MA, Martínez-Guzmán W, Vargas-Ramírez L, Herrera K, González-García M. Prevalence of central sleep apnea during continuous positive airway pressure (CPAP) titration in subjects with obstructive sleep apnea syndrome at an altitude of 2640 m. Sleep Med 2015;16(3):343-346. doi: 10.1016/j.sleep.2014.09.022

  30. Latshang TD, Nussbaumer-Ochsner Y, Henn RM, et al. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA 2012;308(22):2390-2398. doi: 10.1001/jama.2012.94847.

  31. Wang X, Ouyang Y, Wang Z, Zhao G, Liu L, Bi Y. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 2013;169(3):207-214. doi: 10.1016/j.ijcard.2013.08.088.

  32. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999;14(1):179-184.

  33. Badran M, Ayas N, Laher I. Cardiovascular complications of sleep apnea: role of oxidative stress. Oxid Med Cell Longev 2014;2014:985258. doi: 10.1155/2014/985258.

  34. Israel LP, Benharoch D, Gopas J, Goldbart AD. A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome. Sleep 2013;36(12):1947-1955. doi: 10.5665/sleep.3236.

  35. Ozkan Y, Firat H, Simşek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008;12(2):149-154.

  36. Ciccone MM, Scicchitano P, Zito A, et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 2014;19(2):1651-1662. doi: 10.3390/molecules19021651.

  37. Cho ER, Kim H, Seo HS, Suh S, Lee SK, Shin C. Obstructive sleep apnea as a risk factor for silent cerebral infarction. J Sleep Res 2013;22(4):452-458. doi: 10.1111/jsr.12034.

  38. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107(8):1129-1134.

  39. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007;176(7):706-712.

  40. McEvoy RD, Antic NA, Heeley E, et al.; SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375(10):919-931. doi: 10.1056/NEJMoa1606599.

  41. Lim S, Barter P. Antioxidant effects of statins in the management of cardiometabolic disorders. J Atheroscler Thromb 2014;21(10):997-1010.

  42. Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens 2015;29(12):705-712. doi: 10.1038/jhh.2015.15.

  43. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011;58(5):811-817. doi: 10.1161/HYPERTENSIONAHA.111.179788.

  44. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283(14):1829-1836.

  45. Baguet JP, Barone-Rochette G, Pépin JL. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 2009;23(7):431-443. doi: 10.1038/jhh.2008.147

  46. Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010;6(4):363-368.

  47. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107(1):68-73.

  48. Fava C, Dorigoni S, Dalle Vedove F, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest 2014;145(4):762-771.

  49. Mohsenin V. Obstructive sleep apnea: a new preventive and therapeutic target for stroke: a new kid on the block. Am J Med 2015;128(8):811-816. doi: 10.1016/j.amjmed.2015.01.037

  50. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353(19):2034-2041.

  51. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172(11):1447-1451.

  52. Parra O, Sánchez-Armengol A, Capote F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res 2015;24(1):47-53. doi: 10.1111/jsr.12181.

  53. Martínez-García MA, Soler-Cataluna JJ, Ejarque-Martínez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180(1):36-41. doi: 10.1164/rccm.200808-1341OC.

  54. Shahar E, Lee S, Kim J, Duval S, Barber C, Luepker RV. Hospitalized heart failure: rates and long-term mortality. J Card Fail 2004;10(5):374-379.

  55. Costanzo MR, Khayat R, Ponikowski P, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol 2015;65(1):72-84. doi: 10.1016/j.jacc.2014.10.025.

  56. Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 2001;119(6):1827-1835.

  57. Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol (1985). 1992;72(2):583-589.

  58. Brinker JA, Weiss JL, Lappe DL, et al. Leftward septal displacement during right ventricular loading in man. Circulation 1980;61(3):626-633.

  59. Tolle FA, Judy WV, Yu PL, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol Respir Environ Exerc Physiol 1983;55(6):1718-1724.

  60. Sun H, Shi J, Li M, Chen X. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS One 2013;8(5):e62298. doi: 10.1371/journal.pone.0062298.

  61. Leung RS. Sleep-disordered breathing: autonomic mechanisms and arrhythmias. Prog Cardiovasc Dis 2009;51(4):324-338. doi: 10.1016/j.pcad.2008.06.002.

  62. Simantirakis EN, Schiza SI, Marketou ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 2004;25(12):1070-1076.

  63. Tanigawa T, Yamagishi K, Sakurai S, et al. Arterial oxygen desaturation during sleep and atrial fibrillation. Heart 2006;92(12):1854-1855.

  64. Mehra R, Benjamin EJ, Shahar E, et al.; Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173(8):910-916.

  65. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352(12):1206-1214.

  66. Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013;62(4):300-305. doi: 10.1016/j.jacc.2013.03.052.

  67. Aronson D, Darawsha W, Atamna A, et al. Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure. J Card Fail 2013;19(10):665-671. doi: 10.1016/j.cardfail.2013.08.007.

  68. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D42-D50. doi: 10.1016/j.jacc.2013.10.032.

  69. Simonneau G, Gatzoulis MA, Adatia I, et al. [Updated clinical classification of pulmonary hypertension]. Turk Kardiyol Dern Ars 2014;42 Suppl 1:45-54.

  70. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996;109(2):380-386.

  71. Niijima M, Kimura H, Edo H, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1999;159(6):1766-1772.

  72. Minic M, Granton JT, Ryan CM. Sleep disordered breathing in group 1 pulmonary arterial hypertension. J Clin Sleep Med 2014;10(3):277-283. doi: 10.5664/jcsm.3528.

  73. Minai OA, Ricaurte B, Kaw R, et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol 2009;104(9):1300-1306. doi: 10.1016/j.amjcard.2009.06.048.

  74. McGuire M, Bradford A. Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats. Eur Respir J 2001;18(2):279-285.

  75. Sajkov D, Wang T, Saunders NA, Bune AJ, McEvoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165(2):152-158.

  76. Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep-inducing apnea. Ann Intern Med 1978;89(4):454-458.

  77. Sforza E, Krieger J, Weitzenblum E, Apprill M, Lampert E, Ratamaharo J. Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am Rev Respir Dis 1990;141(4 Pt 1):866-870.

  78. Sun X, Luo J, Xiao Y. Continuous positive airway pressure is associated with a decrease in pulmonary artery pressure in patients with obstructive sleep apnoea: a meta-analysis. Respirology 2014;19(5):670-674. doi: 10.1111/resp.12314.




2020     |     www.medigraphic.com